GO
Loading...

Opko Health CEO on Cytochromas Acquisition

Monday, 28 Jan 2013 | 6:15 PM ET

Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.